Laura Ekas, Ph.D.
About Laura Ekas, Ph.D.
Laura A. Ekas Education Background
Laura A. Ekas earned a Bachelor of Arts degree in behavioral biology from Johns Hopkins University. She furthered her education by obtaining a Ph.D. in pharmacology and signal transduction from the New York University School of Medicine.
Professional Experience at Alexion Pharmaceuticals
Laura A. Ekas has considerable experience in the pharmaceutical industry. She previously worked at Alexion Pharmaceuticals, where her roles involved global pricing and reimbursement, corporate operations, and investor relations. Her work contributed to the company's focus on delivering innovative and life-transforming therapies.
Consultant Role at Insight Strategy Advisors
Laura A. Ekas served as a Consultant at Insight Strategy Advisors. In this capacity, she focused on key areas such as patient access, pricing, and supply chain strategies. This role involved working with various stakeholders to optimize patient support systems and market access strategies.
Career Progression at Canaccord Genuity Group
Laura A. Ekas held various positions of increasing responsibility at Canaccord Genuity Group. Her roles culminated in her appointment as Vice President of Biotech Equity Research. In this capacity, she was involved in the financial analysis and evaluation of biotech equities, providing insights and strategic advice to clients.
Support for the Michael Mosier Defeat DIPG Foundation
Laura A. Ekas actively supports the Michael Mosier Defeat DIPG Foundation. This foundation is focused on finding a cure for Diffuse Intrinsic Pontine Glioma (DIPG), a rare and aggressive brain tumor that affects children. Her support helps advance research and awareness for this cause.